Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis

ClinicalTrials.gov ID: NCT03987620

Public ClinicalTrials.gov record NCT03987620. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 11:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis (AVVC).

Study identification

NCT ID
NCT03987620
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Scynexis, Inc.
Industry
Enrollment
455 participants

Conditions and interventions

Interventions

  • Ibrexafungerp Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 6, 2019
Primary completion
Mar 28, 2020
Completion
Apr 28, 2020
Last update posted
Sep 7, 2021

2019 – 2020

United States locations

U.S. sites
21
U.S. states
15
U.S. cities
21
Facility City State ZIP Site status
Mesa OB-GYN Mesa Arizona 85209
Red Rocks OBGYN Lakewood Colorado 80228
Planned Parenthood Southern New England New Haven Connecticut 06511
New Generation Medical Research Hialeah Florida 33016
Healthcare Clinical Data Inc North Miami Florida 33161
Physician Care Clinical Research LLC Sarasota Florida 34239
CCT LLC - A VitaLink Company- PPDS West Palm Beach Florida 33409
Mount Vernon Clinical Research, LLC Sandy Springs Georgia 30328
Fellows Research Alliance Inc Savannah Georgia 31406
Rosemark Women Care Specialists Idaho Falls Idaho 83404
Praetorian Pharmaceutical Research, LLC Marrero Louisiana 70072
North County Health Center, Planned Parenthood of the St. Louis Region and Southwest Missouri Florissant Missouri 63033
Clinical Research Center Of Nevada Las Vegas Nevada 89123
Planned Parenthood North Central Southern New Jersey (PPNCSNJ) Hackensack New Jersey 07601
Carolina Institute for Clinical Research - M3 Wake Research Fayetteville North Carolina 28304
Obstetrics and Gynecology Associates of Erie, PC Erie Pennsylvania 16507
Planned Parenthood Southeastern Pennsylvania The Elizabeth Blackwell Health Center Philadelphia Pennsylvania 19107
Fellows Research Alliance Inc Bluffton South Carolina 29910
Chattanooga Medical Research Inc Chattanooga Tennessee 37404
Signature GYN Services, PLLC Fort Worth Texas 76104
Brownstone Clinical Trials, LLC Irving Texas 75062

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03987620, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 7, 2021 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03987620 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →